Cellectis S.A. ADR (CLLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 82,456 | 22,990 | 21,432 | 33,715 | 56,444 |
| Cost of Goods | 36,275 | 11,392 | 2,739 | 2,620 | 1,777 |
| Gross Profit | 46,181 | 11,598 | 18,693 | 31,095 | 54,667 |
| Operating Expenses | 131,893 | 135,542 | 124,523 | 124,365 | 122,747 |
| Operating Income | -85,437 | -123,552 | -105,091 | -92,650 | -67,302 |
| Interest Expense | 17,514 | 3,631 | 3,813 | 18,294 | 7,101 |
| Other Income | 5,468 | 11,971 | 20,571 | 7,261 | 7,148 |
| Pre-tax Income | -97,483 | -115,212 | -88,333 | -103,683 | -67,255 |
| Net Income Continuous | -97,483 | -115,212 | -88,333 | -103,683 | -67,255 |
| Minority Interests | -16,409 | -13,121 | -9,640 | -4,315 | N/A |
| Net Income | $-81,074 | $-102,091 | $-78,693 | $-99,368 | $-67,255 |
| EPS Basic Total Ops | -1.91 | -2.41 | -1.93 | -2.78 | -1.91 |
| EPS Basic Continuous Ops | -2.29 | -2.71 | -2.17 | -2.91 | -1.91 |
| EPS Diluted Total Ops | -1.91 | -2.41 | -1.93 | -2.78 | -1.91 |
| EPS Diluted Continuous Ops | -2.29 | -2.71 | -2.17 | -2.91 | -1.91 |
| EPS Diluted Before Non-Recurring Items | -1.91 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-75,618 | $-116,677 | $-102,714 | $-89,279 | $-65,092 |